Medicare Part D coverage · crinecerfont · RxCUI 2701413
crinecerfont 50 MG/ML Oral Solution [Crenessity]
Per the CMS 2026 Part D formulary file, crinecerfont 50 MG/ML Oral Solution [Crenessity] is covered by 174 Medicare Part D plans (3.4% of enrollable products), averaging Tier 4.2, with prior authorization required on 86.7% of covering formularies.
- 3.4%
- Plan coverage
- 174
- Plans covering
- T4.2
- Avg tier
- 86.7%
- Prior auth required
What the CMS Formulary Data Shows for crinecerfont 50 MG/ML Oral Solution [Crenessity]
Per the CMS 2026 Part D formulary file, crinecerfont 50 MG/ML Oral Solution [Crenessity] (RxNorm concept RXCUI 2701413, generic name crinecerfont) appears on 15 distinct formulary files spanning 174 Medicare Part D plan offerings - 3.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to crinecerfont 50 MG/ML Oral Solution [Crenessity] depends on utilization management as much as tier placement: 86.7% of covering formularies require prior authorization. 0% require step therapy. 60% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry crinecerfont 50 MG/ML Oral Solution [Crenessity] today.
Coverage Details
- Formularies covering
- 15
- Plans covering
- 174
- Coverage rate
- 3.4%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 86.7% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 60% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering crinecerfont 50 MG/ML Oral Solution [Crenessity]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Personal Choice 65 Achieve Rx (PPO) | QCC Insurance Company | T5 | Yes | $0 | PA |
| Keystone 65 Focus Rx (HMO-POS) | Keystone Health Plan East, Inc. | T5 | Yes | $0 | PA |
| Keystone 65 Focus Rx (HMO-POS) | Keystone Health Plan East, Inc. | T5 | Yes | $0 | PA |
| Keystone 65 Basic Rx (HMO) | Keystone Health Plan East, Inc. | T5 | Yes | $0 | PA |
| AmeriHealth Medicare Core (PPO) | Amerihealth Insurance Company OF NEW Jersey | T5 | Yes | $0 | NJ |
| AmeriHealth Medicare Ultimate (PPO) | Amerihealth Insurance Company OF NEW Jersey | T5 | Yes | $0 | NJ |
| Geisinger Gold Preferred Complete Rx (PPO) | Geisinger Indemnity Insurance Company | T5 | Yes | $0 | PA |
| Geisinger Gold Secure Rx (HMO D-SNP) | Geisinger Health Plan | T5 | Yes | $0 | PA |
| Geisinger Gold Classic 360 Rx (HMO) | Geisinger Health Plan | T5 | Yes | $0 | PA |
| Geisinger Gold Classic Essential Rx (HMO) | Geisinger Health Plan | T5 | Yes | $0 | PA |
| Fallon Medicare Plus Orange (HMO) | Fallon Community Health Plan | T5 | Yes | $0 | MA |
| UPMC for Life HMO Premier Rx (HMO) | Upmc Health Plan, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc FOR YOU, Inc | T5 | Yes | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc FOR YOU, Inc | T5 | Yes | $0 | PA |
| UPMC for Life PPO Premier Rx (PPO) | Upmc Health Network, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life PPO Premier Rx (PPO) | Upmc Health Network, Inc. | T5 | Yes | $0 | PA |
| UPMC for Life PPO Essential Care Rx (PPO) | Upmc Health Network, Inc. | T5 | Yes | $0 | PA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is crinecerfont 50 MG/ML Oral Solution [Crenessity] covered by Medicare Part D?
Yes, crinecerfont 50 MG/ML Oral Solution [Crenessity] is covered by 174 Medicare Part D plans (3.4% of all Part D formularies).
What tier is crinecerfont 50 MG/ML Oral Solution [Crenessity] on Medicare Part D plans?
crinecerfont 50 MG/ML Oral Solution [Crenessity] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does crinecerfont 50 MG/ML Oral Solution [Crenessity] require prior authorization?
86.7% of Part D formularies require prior authorization for crinecerfont 50 MG/ML Oral Solution [Crenessity]. Step therapy: 0%. Quantity limits: 60%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- dasatinib 20 MG Oral Tablet T4.2
- rilpivirine 2.5 MG Tablet for Oral Suspension [Edurant] T4.2
- tenofovir disoproxil fumarate 250 MG Oral Tablet [Viread] T4.2
- sodium oxybate 500 MG/ML Oral Solution T4.2
- sapropterin dihydrochloride 100 MG Oral Tablet T4.2
- ivacaftor 125 MG / lumacaftor 200 MG Oral Tablet [ORKAMBI] T4.2
Similar prior-authorization rate
- 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe [Lupron] 86.8% PA
- 0.6 ML pegfilgrastim-cbqv 10 MG/ML Prefilled Syringe [Udenyca] 86.4% PA
- 1.7 ML denosumab-nxxp 70 MG/ML Injection [Bilprevda] 86.4% PA
- trientine hydrochloride 250 MG Oral Capsule 87.1% PA
- levoketoconazole 150 MG Oral Tablet [Recorlev] 87.1% PA
- ondansetron 0.8 MG/ML Oral Solution 86.3% PA